Creatd Sells Fly Flyte Stake to Catheter Precision, Strengthening Financial Position

Creatd, Inc. (OTCQB: CRTDD) announced the sale of its remaining 80% equity stake in subsidiary Fly Flyte, Inc. to Catheter Precision, Inc. (NYSE American: VTAK). The transaction provides Creatd with approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK, significantly strengthening the company's balance sheet. This NYSE-approved deal aligns with Creatd's strategy of developing turnkey operating solutions that prepare businesses for public market listings while retaining minority interests.

The sale positions Creatd as a significant shareholder in VTAK, adding NYSE-listed equity to its growing portfolio of public and private positions across diversified industries. Creatd helps companies overcome structural hurdles and mature into institutionally viable enterprises through its technology and AI-first operational infrastructure. The company acquired Flyte approximately one year ago after initiating due diligence in Q4 2024, implementing a disciplined turnaround strategy focused on operational optimization, technology integration, and targeted revenue growth while positioning the company for acquisition by a nationally-listed platform.

Jeremy Frommer, Chairman and CEO of Creatd, Inc., stated that the company will continue pursuing its own national exchange listing strategy this year without relying on traditional financing structures that often consume companies lacking balance sheet value. "Our recent reverse split, completed without an accompanying financing, was an important step toward meeting those national exchange listing requirements. This asset sale now provides the capital needed to complete the next phase," said Frommer. He emphasized that Creatd creates balance sheet value through acquisition and incubation strategies for exchange-listed entities, where operating businesses can develop for long-term success while leveraging proprietary technology and process.

Frommer described Creatd as one of the few turnaround-focused publicly traded platforms in the small-cap and micro-cap M&A space, expressing intention to institutionalize this model as the company expands its platform. "We also see a significant opportunity to address the structural gap created by the contraction of the middle market over the past two decades. Too many public companies today lack the infrastructure and support needed to reach their full potential. We are building a platform that helps companies stabilize, scale, and ultimately reach national exchange listings while creating lasting value," he continued.

Creatd and VTAK will maintain collaboration through their strategic relationship, including ongoing efforts in aviation and eVTOL logistics platform development. The company expressed gratitude for shareholder support throughout its multi-year transition and remains focused on executing its plan. For more information about Creatd, visit https://www.creatd.com, and for details about Flyte, visit https://www.flyte.travel. The latest news and updates relating to Creatd are available in the company's newsroom at https://tinyurl.com/crtdnewsroom.